Studies on receptor-mediated activation of adenylyl cyclases. III. Regulation by purine nucleotides of the activation of adenylyl cyclases from target organs for prostaglandins, luteinizing hormone, neurohypophyseal hormones and catecholamines. Tissue- and hormone-dependent variations.
D000227:Adenine Nucleotides / Q000494:pharmacology; D000262:Adenylyl Cyclases / Q000494:pharmacology*; D000818:Animals; D001120:Arginine; D002395:Catecholamines / Q000494:pharmacology*; D002415:Cats; D002417:Cattle; D002462:Cell Membrane / Q000187:drug effects / Q000201:enzymology; D003338:Corpus Luteum / Q000187:drug effects / Q000201:enzymology; D005260:Female; D006150:Guanine Nucleotides / Q000494:pharmacology; D006352:Heart Ventricles / Q000187:drug effects / Q000201:enzymology; D006801:Humans; D007292:Inosine Nucleotides / Q000494:pharmacology; D007679:Kidney Medulla / Q000201:enzymology; D007700:Kinetics; D007986:Luteinizing Hormone / Q000494:pharmacology*; D008274:Magnesium / Q000494:pharmacology; D008297:Male; D010761:Phosphorus Radioisotopes; D011247:Pregnancy; D011453:Prostaglandins / Q000494:pharmacology*; D011817:Rabbits; D051381:Rats; D011956:Receptors, Cell Surface / Q000187:drug effects*; D014667:Vasopressins / Q000494:pharmacology*
D000227:Adenine Nucleotides; D002395:Catecholamines; D006150:Guanine Nucleotides; D007292:Inosine Nucleotides; D010761:Phosphorus Radioisotopes; D011453:Prostaglandins; D011956:Receptors, Cell Surface; D014667:Vasopressins; D007986:Luteinizing Hormone; D001120:Arginine; D000262:Adenylyl Cyclases; D008274:Magnesium